Fortrea (FTRE) PT Lowered to $30 at Citi
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St futures decline as oil surge, high yields stoke inflation worries
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Goldman Sachs sees 18% upside for Palantir on sovereign AI growth
- Citi names 5 top chip picks ahead of Q3 earnings
- PepsiCo shares climb after Q3 beat, though company trims profit forecast
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- Applied Digital (APLD) Tops Q1 EPS by 26c, Beats on Revenue
Fortrea (FTRE) PT Lowered to $22 at Evercore ISI
August 12, 2024 1:47 PM EDTEvercore ISI analyst Elizabeth Anderson lowered the price target on Fortrea (NASDAQ: FTRE) to $22.00 (from $27.00) while maintaining a In Line rating.
The analyst comments "If you thought we were done with Olympic themed titles just because the closing ceremony was this weekend,... More
FTRE (FTRE) Misses Q2 EPS by 27c ; Offers Guidance
August 12, 2024 7:04 AM EDTFTRE (NASDAQ: FTRE) reported Q2 EPS of ($0.03), $0.27 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $662.4 million versus the consensus estimate of $797.5 million.
GUIDANCE:
FTRE sees FY2024 revenue of $2.7-2.75 billion, versus the consensus of $2.8... More
Evercore ISI Downgrades Fortrea (FTRE) to In Line
August 8, 2024 5:44 AM EDTEvercore ISI analyst Elizabeth Anderson downgraded Fortrea (NASDAQ: FTRE) from Outperform to In Line with a price target of $27.00 (from $31.00).
The analyst comments "We are moving to the sidelines on FTRE this morning as weaker biotech funding data and pharma R&D spend along with weakening forward indicators for peers who have already reported point to a... More



